Bone 2022:116431
Inflammation in Sickle Cell Disease
In 2017, the Food and Drug Administration approved the medication semaglutide injectable (Ozempic) in the treatment of Type 2 diabetes
Less common, but more serious side effects can include: Pancreatitis Hypoglycemia Allergic reactions (rash, facial swelling, trouble breathing, fainting, rapid heartbeat) Kidney failure Gastrointestinal issues Vision changes Gallbladder issues (stomach pain, fever, jaundice, discolored stool) Differences Mechanism of Action: Semaglutide predominantly functions as a GLP-1 agonist, targeting specific pathways to facilitate its effects
Several factors can influence the design of a dosing protocol for a study
DS, RP, AK, and NS are salaried researchers at Patanjali Research Foundation, an independent research institution within the broader Patanjali group structure